137 related articles for article (PubMed ID: 12919313)
1. Role of cleavage and shedding in human thyrotropin receptor function and trafficking.
Quellari M; Desroches A; Beau I; Beaudeux E; Misrahi M
Eur J Biochem; 2003 Sep; 270(17):3486-97. PubMed ID: 12919313
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
3. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
5. Subunit interactions influence TSHR multimerization.
Latif R; Michalek K; Davies TF
Mol Endocrinol; 2010 Oct; 24(10):2009-18. PubMed ID: 20719860
[TBL] [Abstract][Full Text] [Related]
6. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
7. Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor.
Latif R; Ando T; Davies TF
Endocrinology; 2004 Dec; 145(12):5580-8. PubMed ID: 15319351
[TBL] [Abstract][Full Text] [Related]
8. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of the thyrotropin receptor-beta subunit.
Ciullo I; Latif R; Graves P; Davies TF
Endocrinology; 2003 Jul; 144(7):3176-81. PubMed ID: 12810574
[TBL] [Abstract][Full Text] [Related]
10. Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Apr; 144(4):1324-30. PubMed ID: 12639915
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene.
Costagliola S; Sunthorntepvarakul T; Migeotte I; Van Sande J; Kajava AM; Refetoff S; Vassart G
Thyroid; 1999 Oct; 9(10):995-1000. PubMed ID: 10560953
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
Kosugi S; Shenker A; Mori T
FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
[TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies.
Oda Y; Sanders J; Evans M; Kiddie A; Munkley A; James C; Richards T; Wills J; Furmaniak J; Smith BR
Thyroid; 2000 Dec; 10(12):1051-9. PubMed ID: 11201849
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor.
Claus M; Neumann S; Kleinau G; Krause G; Paschke R
J Mol Med (Berl); 2006 Nov; 84(11):943-54. PubMed ID: 16955277
[TBL] [Abstract][Full Text] [Related]
15. TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.
Rapoport B; McLachlan SM
Endocr Rev; 2016 Apr; 37(2):114-34. PubMed ID: 26799472
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
[TBL] [Abstract][Full Text] [Related]
17. Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.
Agretti P; De Marco G; Pinchera A; Vitti P; Bernal J; Tonacchera M
J Endocrinol Invest; 2007 Apr; 30(4):279-84. PubMed ID: 17556863
[TBL] [Abstract][Full Text] [Related]
18. On the functional importance of thyrotropin receptor intramolecular cleavage.
Chazenbalk GD; Tanaka K; McLachlan SM; Rapoport B
Endocrinology; 1999 Oct; 140(10):4516-20. PubMed ID: 10499506
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of shedding of a soluble form of the TSH receptor].
Misrahi M; Couet J; Milgrom E
Ann Endocrinol (Paris); 1997; 58(5):365-9. PubMed ID: 9685994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
